FDA Drug Recalls

Recalls / Class II

Class IID-0044-2025

Product

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90

Affected lot / code info
Lot# NB240873, Exp 03/31/2026

Why it was recalled

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Recalling firm

Firm
Cipla USA, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10 Independence Blvd, N/A, Warren, New Jersey 07059-2730

Distribution

Quantity
N/A
Distribution pattern
USA nationwide.

Timeline

Recall initiated
2024-10-23
FDA classified
2024-11-12
Posted by FDA
2024-11-20
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0044-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls